La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Nova Eye Medical Résultats passés
Passé contrôle des critères 0/6
Nova Eye Medical's earnings have been declining at an average annual rate of -16.8%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been declining at an average rate of 17.3% per year.
Informations clés
-16.8%
Taux de croissance des bénéfices
-13.7%
Taux de croissance du BPA
Medical Equipment Croissance de l'industrie | 5.8% |
Taux de croissance des recettes | -17.3% |
Rendement des fonds propres | -84.1% |
Marge nette | -76.2% |
Dernière mise à jour des bénéfices | 31 Dec 2023 |
Mises à jour récentes des performances passées
Recent updates
Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)
Aug 06Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward
Apr 18Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?
Mar 26News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts
Jan 19Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce
Dec 27We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate
Sep 03Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified
Apr 17Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?
Dec 16We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully
Aug 27Ventilation des recettes et des dépenses
Comment Nova Eye Medical gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
31 Dec 23 | 19 | -14 | 22 | 0 |
30 Sep 23 | 18 | -15 | 22 | 0 |
30 Jun 23 | 17 | -15 | 22 | 0 |
31 Mar 23 | 16 | -13 | 21 | 0 |
31 Dec 22 | 15 | -11 | 21 | 0 |
30 Sep 22 | 14 | -9 | 19 | 0 |
30 Jun 22 | 13 | -7 | 17 | 0 |
31 Mar 22 | 13 | -7 | 16 | 0 |
31 Dec 21 | 13 | -6 | 15 | 0 |
30 Sep 21 | 13 | -5 | 14 | 0 |
30 Jun 21 | 13 | -4 | 13 | 0 |
31 Dec 20 | 12 | -9 | 12 | 0 |
30 Sep 20 | 13 | -10 | 13 | 0 |
30 Jun 20 | 13 | -10 | 14 | 0 |
31 Dec 19 | 16 | -6 | 16 | 0 |
30 Sep 19 | 16 | -6 | 17 | 0 |
30 Jun 19 | 16 | -7 | 18 | 0 |
31 Mar 19 | 48 | -7 | 34 | 1 |
31 Dec 18 | 49 | -6 | 34 | 1 |
30 Sep 18 | 64 | -6 | 37 | 1 |
30 Jun 18 | 79 | -5 | 41 | 1 |
31 Mar 18 | 77 | -5 | 36 | 1 |
31 Dec 17 | 75 | -5 | 32 | 1 |
30 Sep 17 | 73 | -3 | 31 | 1 |
30 Jun 17 | 72 | -1 | 29 | 1 |
31 Mar 17 | 72 | 1 | 28 | 1 |
31 Dec 16 | 73 | 3 | 27 | 1 |
30 Sep 16 | 73 | 3 | 26 | 1 |
30 Jun 16 | 73 | 3 | 26 | 1 |
31 Mar 16 | 70 | 3 | 24 | 1 |
31 Dec 15 | 67 | 2 | 22 | 1 |
30 Sep 15 | 65 | 2 | 22 | 1 |
30 Jun 15 | 63 | 2 | 21 | 1 |
31 Mar 15 | 61 | 1 | 20 | 1 |
31 Dec 14 | 59 | 1 | 19 | 1 |
30 Sep 14 | 57 | 1 | 18 | 1 |
30 Jun 14 | 54 | 1 | 17 | 1 |
31 Mar 14 | 51 | 0 | 16 | 1 |
31 Dec 13 | 47 | -1 | 15 | 1 |
30 Sep 13 | 45 | -1 | 15 | 1 |
Des revenus de qualité: EYE is currently unprofitable.
Augmentation de la marge bénéficiaire: EYE is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: EYE is unprofitable, and losses have increased over the past 5 years at a rate of 16.8% per year.
Accélération de la croissance: Unable to compare EYE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: EYE is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Rendement des fonds propres
ROE élevé: EYE has a negative Return on Equity (-84.09%), as it is currently unprofitable.